收费全文 | 541737篇 |
免费 | 29134篇 |
国内免费 | 528篇 |
耳鼻咽喉 | 6774篇 |
儿科学 | 17393篇 |
妇产科学 | 12753篇 |
基础医学 | 94017篇 |
口腔科学 | 12587篇 |
临床医学 | 49655篇 |
内科学 | 98150篇 |
皮肤病学 | 12080篇 |
神经病学 | 35636篇 |
特种医学 | 20073篇 |
外国民族医学 | 54篇 |
外科学 | 79963篇 |
综合类 | 7753篇 |
现状与发展 | 2篇 |
一般理论 | 112篇 |
预防医学 | 39547篇 |
眼科学 | 12127篇 |
药学 | 42183篇 |
1篇 | |
中国医学 | 1135篇 |
肿瘤学 | 29404篇 |
2019年 | 4058篇 |
2018年 | 5905篇 |
2017年 | 4299篇 |
2016年 | 5051篇 |
2015年 | 5560篇 |
2014年 | 7396篇 |
2013年 | 10885篇 |
2012年 | 16152篇 |
2011年 | 18008篇 |
2010年 | 10309篇 |
2009年 | 9127篇 |
2008年 | 16292篇 |
2007年 | 18034篇 |
2006年 | 17560篇 |
2005年 | 16796篇 |
2004年 | 16354篇 |
2003年 | 15767篇 |
2002年 | 15234篇 |
2001年 | 22815篇 |
2000年 | 23412篇 |
1999年 | 19272篇 |
1998年 | 5373篇 |
1997年 | 4510篇 |
1996年 | 4534篇 |
1995年 | 4253篇 |
1992年 | 14664篇 |
1991年 | 16101篇 |
1990年 | 16203篇 |
1989年 | 15861篇 |
1988年 | 14503篇 |
1987年 | 14377篇 |
1986年 | 13361篇 |
1985年 | 12870篇 |
1984年 | 9532篇 |
1983年 | 8119篇 |
1982年 | 4255篇 |
1979年 | 9063篇 |
1978年 | 6489篇 |
1977年 | 5245篇 |
1976年 | 5592篇 |
1975年 | 6728篇 |
1974年 | 7528篇 |
1973年 | 7260篇 |
1972年 | 6682篇 |
1971年 | 6394篇 |
1970年 | 5975篇 |
1969年 | 5540篇 |
1968年 | 5238篇 |
1967年 | 4669篇 |
1966年 | 4029篇 |
![点击此处可从《Journal of pineal research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
![点击此处可从《Journal of the European Academy of Dermatology and Venereology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Method: Socio-demographics, early-life adversity (ELA), individual quality of life (iQoL), and mental and physical health of 270 individuals (Mage = 66.82 years, 71.5% female) were assessed. Polynomial regressions and mediation analyses were conducted.
Results: Significant inverse U-shaped associations were found between ELA and iQoL (β = ?.59, p = .005) and between ELA and mental health (β = ?.64, p = .002), but not between ELA and physical health. Furthermore, mental health significantly mediated the relationship between ELA and iQoL (b = ?.84, BCa CI [?1.66, ?.27]).
Conclusion: Highest level of individual quality of life (i.e. successful aging) was related to a moderate amount of ELA. Additionally, mental health significantly mediated this relationship. These findings suggest that some amount of ELA could be beneficial for successful aging. Resource-focused interventions are needed to improve health and promote successful aging for an underdetected, at-risk subgroup with low early-life adversity. 相似文献
Background
Current blunt cerebrovascular injury (BCVI) grading grossly differentiates injury characteristics such as luminal stenosis (LS) and aneurysmal disease. The effect of increasing degree of LS beyond the current BCVI grading scale on stroke formation is unknown.Study Design
BCVI over a 3-year period were retrospectively reviewed. To investigate influence of LS beyond the BCVI grading scale within aneurysmal and non-aneurysmal BCVI, grade 2 BCVI were subdivided into BCVI with ≥ 25% and ≤ 50% LS and BCVI with > 50% and ≤ 99% LS. Grade 3 BCVI were subdivided into BCVI with pseudoaneurysm (PSA) without LS and BCVI with PSA and LS. We hypothesized increased LS beyond the current BCVI grade distinctions would be associated with higher rates of stroke formation.Results
312 BCVI were included, of which 140 were carotid BCVI and 172 vertebral BCVI. Sixteen carotid BCVI underwent endovascular intervention (EI) and 19 suffered a stroke. In carotid BCVI stroke rates increased sequentially with BCVI grade except in grade 3. There was a stroke rate of 12% in grade 1 carotid BCVI, 18% in grade 2, 6% in grade 3, and 31% in grade 4. In subgroup analysis for grade 2 carotid BCVI, BCVI with > 50% and ≤ 99% LS had higher rates of stroke (22% vs. 15%, p?=?0.44) than BCVI with ≥ 25% and ≤ 50% LS. In subgroup analysis of grade 3 carotid BCVI, BCVI with PSA and LS had higher rates of stroke (9% vs. 4%, p?=?0.48) than BCVI with PSA without LS. Higher rates of EI in grade 2 carotid BCVI with > 50% and ≤ 99% LS (22% vs. 5%, p?=?0.14) and grade 3 carotid BCVI with PSA and LS (35% vs. 4%, p?=?0.01) were noted in subgroup analysis.Conclusion
Higher percentage LS beyond the currently used BCVI grading scale has a non-significantly increased rate of stroke in both aneurysmal and non-aneurysmal BCVI. Grade 3 BCVI with PSA and LS seems to be a high-risk subgroup. Use of EI confounds modern measurement of stroke risk in higher LS BCVI. 相似文献Purpose
A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).Methods and Materials
A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.Results
The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.Conclusions
Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making. 相似文献- Download : Download high-res image (215KB)
- Download : Download full-size image